MetaCap

Acadia Healthcare Company Inc. (ACHC)

NASDAQ: ACHCHealth CareMedical SpecialitiesUSD

34.60+0.13 (+0.38%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

ACHC stock chart

Technical analysis

Key statistics

All statistics
EPS (TTM)
-$12.44
52-week range
11.43 – 39.70
Day range
33.80 – 35.15
Volume / Avg
1.92M / 1.84M
Beta
—

52-week range

$11.43$39.70

ACHC stock today

Acadia Healthcare (ACHC) closed at $34.60 on Nov 20, up 0.38% (+$0.13), versus the S&P 500's 3.70% decline. Shares are 12.8% below their 52-week high of $39.70, set on Nov 9, 2026 and 202.7% above the 52-week low of $11.43, near the top of the past year's range. ACHC is up 143.8% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 127.9%.

Acadia Healthcare has posted a net loss over the last twelve months (EPS of -$12.44), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About Acadia Healthcare

Company profile

Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico. The company owns and operates acute inpatient psychiatric facilities; specialty treatment facilities comprising residential recovery facilities and eating disorder facilities; comprehensive treatment centers; and residential treatment centers, as well as facilities providing outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.

Industry
Medical Specialities
CEO
Ms. Debra K. Osteen
Headquarters
Franklin, TN
Employees
19,000

Financial highlights

Full financials

In fiscal 2025, Acadia Healthcare generated $3.31 billion in revenue, up 5.0% from fiscal 2024, its 7th consecutive year of revenue growth. Acadia Healthcare reported a net loss of $1.10 billion, compared with net income of $255.6 million a year earlier. Diluted earnings per share came in at -$12.16, down from $2.78.

Acadia Healthcare annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue$3.31B$3.15B$2.93B$2.61B$2.31B
Growth+5.04%+7.69%+12.20%+12.79%+10.74%
Net income$-1.10B$255.61M$-21.67M$273.14M$190.63M
EPS (diluted)$-12.16$2.78$-0.24$2.98$2.10

Analyst forecast

Forecast

Consensus (14 analysts)

buy

Avg. price target

$39.07+12.92%

  • Strong buy 2
  • Buy 6
  • Hold 5
  • Sell 0
  • Strong sell 1

Target range

Low $19.00High $46.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 4, 2026
EPS actual vs est.
$0.38 vs $0.46
Surprise
-17.39%

ACHC news

All ACHC news

Acadia Healthcare peers

Health Care sector
ACHC peer companies
CompanyPrice% ChgMarket capCompare
CDNACareDx Inc.70.00-2.67%$3.68Bvs ACHC
CELCCelcuity Inc.53.35-5.26%$2.61Bvs ACHC
BLLNBillionToOne Inc. Class A89.92-0.31%$4.30Bvs ACHC
VCYTVeracyte Inc.25.13+0.36%$2.03Bvs ACHC
CLOVClover Health Investments Corp. Class A3.73-1.06%$2.00Bvs ACHC
GRALGRAIL Inc.99.25-5.33%$4.46Bvs ACHC
FTREFortrea Holdings Inc.18.55-7.94%$1.79Bvs ACHC
PSNLPersonalis Inc.14.27-3.06%$1.55Bvs ACHC

Indexes, lists and sector

Acadia Healthcare stock FAQ

What is Acadia Healthcare's stock price today?

ACHC last traded at $34.60 as of Nov 20, 4:00 PM EST, up 0.38% on the day. Prices are delayed at least 15 minutes.

Does Acadia Healthcare pay a dividend?

No. Acadia Healthcare does not currently pay a regular cash dividend.

Who is Acadia Healthcare's CEO?

Ms. Debra K. Osteen is the chief executive officer of Acadia Healthcare Company Inc., which has about 19,000 employees.

Has ACHC ever split its stock?

Yes. The most recent ACHC stock split was a 1-for-4 split on Nov 1, 2011.

What is the ACHC 52-week high?

The 52-week high for ACHC is $39.70 and the 52-week low is $11.43. The stock is currently 12.8% below its high.

Compare ACHC